(Q57839539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Emerging drugs for spinal cord injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Darryl C Baptiste

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Emerging Drugs

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

63-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology, demographics, and pathophysiology of acute spinal cord injury

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Epidemiology of traumatic spinal cord injury in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Apoptosis after traumatic human spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

White matter injury mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Targeting recovery: priorities of the spinal cord-injured population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Recruitment and early treatment in a multicenter study of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Measurements and recovery patterns in a multicenter study of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Strategies of medical intervention in the management of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Update on the treatment of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Features of skin-coincubated macrophages that promote recovery from spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Spinal cord injury: time to move?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Demyelination in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The current status of studies of aminopyridines in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Suppression of the onset of myelination extends the permissive period for the functional repair of embryonic spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Rho kinase, a promising drug target for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Effects of phosphodiesterase inhibitors on cytokine production by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Rolipram reduces excitotoxic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Cytokines and Neurotrophins Interact in Normal and Diseased States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The effect of the sodium channel blocker QX-314 on recovery after acute spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Strategies to promote neural repair and regeneration after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Anatomical repair of nerve membranes in crushed mammalian spinal cord with polyethylene glycol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Neuroprotection from secondary injury by polyethylene glycol requires its internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The role of inflammation in CNS injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Mood stabilizers: protecting the mood...protecting the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

Axons from CNS neurones regenerate into PNS grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.13.1.63

21 January 2018

Identifiers

DOI

10.1517/14728214.13.1.63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18321149%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference